Devin Binder, MD, PhD, Associate Professor in residence at the University of California-Riverside, is both a neurosurgeon and neuroscientist. Dr. Binder’s more recent research projects have included mechanisms of epileptic seizures and understanding why individuals with autism are hypersensitive to sound.
FRAXA Seminar Series This virtual seminar series addresses a wide range of current topics in Fragile X research. Hosted by FRAXA and organized by Michael Tranfaglia, MD and Patricia Cogram, PhD, sessions feature outstanding speakers from universities and the biotech and pharmaceutical industries. Presentation Summary Craig Erickson - Translational medicine and mechanistic studies of brain neurophysiology in Fragile X Syndrome: A NIH Center Overview Ernest Pedapati - Network Mechanisms, Biomarkers, and Pharmacology of Fragile X Syndrome in Humans Devin Binder - Network Mechanisms of Neurophysiology and Behavior in mouse models of Fragile X Syndrome Kimberly Huber - FMRP Regulation of local and long-range neocortical circuits in the mouse: Links with EEG phenotypes About the SpeakersCraig A. Erickson, MD Professor of Psychiatry at Cincinnati Children's Hospital and the University of Cincinnati College of Medicine Craig Erickson is the director of the Cincinnati Fragile X Research and Treatment Center. Craig has devoted his careerRead more
In this Fragile X research webinar we hear from Devin K. Binder, MD, PhD, Professor, University of California at Riverside Medical School and Khaleel Razak, PhD, Professor, University of California at Riverside as they present about Mechanisms and Biomarkers of Sensory Hypersensitivity in the fmr1 Knockout Mouse.
With a $90,000 grant from FRAXA Research Foundation over 2018-2019, Drs. Devin Binder, Iryna Ethell, and Patricia Pirbhoy at the University of California at Riverside aim to understand – and reverse – hypersensitivity to sound in Fragile X syndrome.